Evaluation of hormonal and metabolic factors related to depression in reproductive age women
Open Access
- 30 January 2020
- journal article
- research article
- Published by Instituto Nacional de Psiquiatria Ramon de la Fuente Muniz in Salud mental
- Vol. 43 (1) , 35-41
Abstract
Introduction. Major depressive disorder (MDD) is a prevalent disease affecting women more than men worldwide. Various factors are involved in the genesis of depression, including hormones such as testosterone and certain metabolic factors Objective. To evaluate hormone levels and metabolic variables in women with major depression and healthy controls. Method. A cross-sectional, comparative analytical study was conducted in 40 participants, 23 patients with an MDD diagnosis and 17 controls, all of women in reproductive age between the ages of 18 and 45. Sociodemographic variables, hormonal profile, and metabolic variables were assessed and the 17-item Hamilton Depression Scale was used to evaluate depressive symptoms. Results. No statistically significant differences were observed between the groups in the hormonal and metabolic variables explored. Nevertheless, it was observed that the lower the testosterone levels and the higher the serum glucose levels, the more intense depressive symptoms were. Discussion and conclusion. Testosterone is associated with a lower depressive symptoms score on the Hamilton Depression scale, suggesting a potential antidepressant effect, whereas high glucose levels are associated with a higher score on this scale. We believe that the measurement of hormonal and metabolic variables in women can contribute to a better understanding of the pathophysiology of depression.Keywords
This publication has 29 references indexed in Scilit:
- Steroid secretion in healthy agingPsychoneuroendocrinology, 2019
- Assessment of hormonal alterations in major depressive disorder: A clinical studyPsych Journal, 2019
- Testosterone is related to GABA+ levels in the posterior-cingulate in unmedicated depressed women during reproductive lifeJournal of Affective Disorders, 2019
- Longitudinal change instead of baseline testosterone predicts depressive symptomsPsychoneuroendocrinology, 2018
- Why is depression more common among women than among men?The Lancet Psychiatry, 2017
- Asymmetric effects of emotion on mnemonic interferenceNeurobiology of Learning and Memory, 2014
- Sex differences in anxiety and depression: Role of testosteroneFrontiers in Neuroendocrinology, 2014
- Neurogenesis and generalization: a new approach to stratify and treat anxiety disordersNature Neuroscience, 2012
- Depression and Treatment Among U.S. Pregnant and Nonpregnant Women of Reproductive Age, 2005–2009Journal of Women's Health, 2012
- Salivary testosterone: Associations with depression, anxiety disorders, and antidepressant use in a large cohort studyJournal of Psychosomatic Research, 2012